Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medistem makes Alan Lewis CEO

This article was originally published in Clinica

Executive Summary

Adult stem cell company Medistem has appointed Dr Alan Lewis CEO and a member of the board of directors. Dr Lewis has been a member of Medistem's scientific advisory board since January 2012. He has previously served as CEO of Signal Therapeutics, Novocell and the Juvenile Diabetes Research Foundation, and is currently a board member of BioMarin. He replaces Dr Thomas Ichim, who has served as CEO since 2008 and has now been appointed Medistem's president and chief scientific officer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099540

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel